Bionexo declares ninth acquisition and advances in plan to be the biggest healthtech in Latin America

The company closed an agreement for the purchase of the Pernambuco startup Síntese B2B, which operates in the North and Northeast regions. “It’s a win-win for all sides of the chain”, says CEO Rafael Barbosa in an exclusive interview

In its ninth acquisition, Bionexo announced this Thursday (11) the agreement with Pernambuco-based Síntese B2B, a startup for the purchase of hospital supplies that operates in the North and Northeast regions. The deal, which still needs to be approved by CADE, will integrate 470 new customers into the Bionexo network – bringing the number of institutions linked to the 30,000 healthcare providers that are part of the company’s ecosystem to almost 3,000.

“With the acquisition, suppliers that are currently on our platform will have access to more buyers. At the same time, we will be able to offer Síntese’s customers a larger portfolio of purchases. It’s a win-win for all sides of the chain”, explains the CEO, Rafael Barbosa, in an exclusive interview with NegNews. The objective, according to the executive, is to “create one of the largest B2B healthcare platforms in all of Latin America”.

Before the term ‘healthtech’ emerged, as highlighted by Barbosa, Bionexo already offered digital solutions for management in the health sector. The focus is on connecting hospitals and clinics with suppliers of supplies and medicines through a marketplace – which currently moves R$16 billion annually.

The latest acquisition is part of Bionexo’s strategy, founded two decades ago by Maurício Barbosa, who is currently chairman of the Board of Directors, to accelerate inorganic growth – a process that was intensified after a BRL 440 million contribution from Bain Capital Tech Opportunities in October of last year. Since then, the company has already acquired Clínica nas Nuvens and BeeCare, which offer digitalization services for healthcare management.

“Our way of buying companies involves always asking that ‘build or buy’ question, that is, if we build or if we buy certain solutions or portfolios. We have been trying to build a base of offering products and services that touch different links in the supply chain”, he says to the CEO.

With Síntese B2B, healthtech adds to its ecosystem a potential of around R$ 1.6 billion per year in sales volume. Founded in 2001 and headquartered in Recife, the company offers a platform for the purchase and sale of inputs through the Software as a Service (SaaS) model, similar to Bionexo.

“For us, the operation represents joining forces to transform the healthcare sector through technology,” said Bertrand Gourgue, founder and CEO of Síntese B2B, in a statement. The acquisition by Bionexo comes just over a year after the startup from Pernambuco received a round of investments from KPLT, one of the main venture capital managers in Brazil, together with Interplayers.

“The technology needs in the healthcare sector are, in practice, endless. But the idea is that we can create a technological platform base that serves the ecosystem based on technology”, emphasizes Rafael Barbosa, to the NegNews.

Source: Época Negócios